Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) Research & Development (2016 - 2025)

Bio Key International's Research & Development history spans 16 years, with the latest figure at $683620.0 for Q3 2025.

  • For Q3 2025, Research & Development rose 4.82% year-over-year to $683620.0; the TTM value through Sep 2025 reached $2.6 million, up 5.61%, while the annual FY2024 figure was $2.5 million, 4.85% up from the prior year.
  • Research & Development for Q3 2025 was $683620.0 at Bio Key International, up from $636027.0 in the prior quarter.
  • Across five years, Research & Development topped out at $833381.0 in Q4 2022 and bottomed at $441651.0 in Q1 2021.
  • The 5-year median for Research & Development is $636027.0 (2025), against an average of $652620.6.
  • The largest annual shift saw Research & Development surged 97.64% in 2021 before it tumbled 36.14% in 2023.
  • A 5-year view of Research & Development shows it stood at $809856.0 in 2021, then increased by 2.9% to $833381.0 in 2022, then dropped by 29.46% to $587900.0 in 2023, then grew by 12.29% to $660151.0 in 2024, then rose by 3.56% to $683620.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Research & Development are $683620.0 (Q3 2025), $636027.0 (Q2 2025), and $595775.0 (Q1 2025).